Is UnitedHealth Group Stock a Buy After Earnings?
UnitedHealth Group stock is higher Tuesday after the insurance giant beat expectations for its second quarter. Here's what you need to know.


UnitedHealth Group (UNH) is the best Dow Jones stock Tuesday after the health insurance giant topped analysts' expectations for its second quarter.
In the three months ended June 30, UnitedHealth's revenue increased 6.4% year-over-year to $98.9 billion, thanks in part to a 6.1% rise in premiums to $76.9 billion. UNH's earnings per share (EPS) were up 10.7% from the year-ago period to $6.80.
These results "reflect diversified and durable growth, and a commitment to ensuring high quality care is available to every person we are privileged to serve," UnitedHealth CEO Andrew Witty said on the company's conference call. "In the first half of the year, revenues grew by nearly $14 billion, with strong contributions from across the enterprise, led by double-digit growth at Optum. UnitedHealth Group enters the second half of the year with continuing and broad-based growth momentum."

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
UnitedHealth's top- and bottom-line results came in ahead of analysts' expectations. According to Yahoo Finance, Wall Street was anticipating revenue of $98.8 billion and earnings of $6.66 per share.
The company also said that the total number of people served by its domestic commercial offerings increased 8.8% year-over-year to 29.6 million, while the total number of people served by its Medicare Advantage plans was up 2.3% to 7.8 million.
As a result of its performance in the first half of the year, UnitedHealth affirmed its full-year outlook, which calls for EPS to arrive between $27.50 to $28 – a range that satisfies analysts' expectations for earnings of $27.59 per share.
Should investors buy UnitedHealth after earnings?
While the decision on whether investors should buy UNH stock after earnings is ultimately their own and dependent upon their personal goals, Wall Street is overwhelmingly bullish toward the blue chip stock.
According to S&P Global Market Intelligence, the average analyst target price for UNH is $576.35, representing implied upside of nearly 6% to current levels. Additionally, of the 28 analysts that cover the stock, 19 rate it a Strong Buy, eight rate it a Buy and one rates it a Hold. This works out to a consensus recommendation of a Strong Buy.
Speaking for the bulls is Truist Securities analyst David MacDonald, who has a Buy rating and $600 price target on UNH. Thanks to strong cash flow generation and meaningful financial flexibility, MacDonald expects "the company's strong financial footing to continue to drive a virtuous cycle of fueling ongoing growth investment in the core business, expansion of capabilities, M&A and shareholder value creation."
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Stock Market Today: Stocks Skid Into Another Risk-Off Turn
The promise of the AI revolution can't overcome flickering hopes for a "Fed put."
By David Dittman Published
-
With DOGE Making Cuts at National Parks, Can You Still Use Your Senior Pass?
If you are a U.S. citizen or permanent resident 62 or older, you can still use your Senior Pass at any and all National Parks in the U.S. Here's what the Senior Pass is and how to use it.
By Kathryn Pomroy Published
-
Stock Market Today: Stocks Skid Into Another Risk-Off Turn
The promise of the AI revolution can't overcome flickering hopes for a "Fed put."
By David Dittman Published
-
How to Survive Market Mayhem
2025 is turning out to be a turbulent year for the market, but don't panic. Here are four ways investors can ride out the storm.
By Jeffrey R. Kosnett Published
-
Alternative Investments Under Trump: What You Need to Know
As access to alternative markets opens up, retail investors looking to enhance their long-term financial outcomes have more opportunities to carefully consider.
By Henry Yoshida Published
-
Beware of TV/Billboard Personal Injury Law Firms: Here's Why
If you or someone you know is tempted to hire a so-called settlement mill to handle a personal injury case, here are some reasons to reconsider.
By H. Dennis Beaver, Esq. Published
-
How Small Businesses Can Clear the Economic Hurdles Ahead
Shifting rules on taxes, trade and regulation are creating uncertainty for SMBs. Owners can overcome that by focusing on efficiency, flexibility and investment.
By Mark Valentino Published
-
Stock Market Today: Dow Adds 353 Points Despite Soft Retail Sales
Investors and traders shake off another set of shaky economic numbers and send 10 of 11 sectors higher on Monday.
By David Dittman Published
-
CoreWeave IPO: Should You Buy CRWV Stock?
The CoreWeave IPO will mark the biggest public offering of the year, with the AI cloud company expected to start trading on the Nasdaq in late March.
By Karee Venema Published
-
Nvidia Stock's Been Growing for Years. Just Look At Its 100,000% Return
Nvidia shareholders have had to stomach intense volatility over the years, but they have come out on top thanks to the AI chipmaker's bellwether status.
By Louis Navellier Published